Continued commercial progress with US reference laboratory

MAR

Q-linea AB (publ) (OMX: QLINEA) today announces contract negotiations continue between Q-linea, Inc. and a large US reference laboratory, with an agreement anticipated in February 2025.

Initial sites have been identified for early deployment of ASTar units. VP of US Commercial Operations Jim Kathrein states, “We are excited by this progress. The healthcare industry has never been more focused on improving sepsis management and patient outcomes. We look forward to partnering with managed groups to increase market awareness to offer rapid antibiotic susceptibility testing results with MICs for patients with bacteremia. We are delivering much needed results for life-threatening infections that clinicians can trust.”

Previous communication (October 21, 2024): https://qlinea.com/mfn_news/us-reference-laboratory-completes-astar-evaluation/?ln=en

Datum 2025-01-24, kl 09:17
Källa MFN
Kom igång med ditt sparande på bara några minuter! Hos Avanza handlar du aktier från 0 kr på Stockholmsbörsen och får tillbaka alla fondavgifter (ja, alla!) upp till 50 000 kr i samlat sparande. Kanske är det därför Avanza har Sveriges nöjdaste sparare 15 år i rad.
Investeringar innebär en risk